Loading…
Back To Schedule
Thursday, November 21 • 9:35am - 9:55am
Enabling New Medicines: From Candidate to the Clinic- Clinical trial biospecimen management: A clinical lab perspective

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Multiple pre-analytical issues are routinely encountered within clinical trials. Bioanalytical laboratories attempt to control for these variables during assay validation, but are often challenged by real world conditions and logistical constraints. In this talk we’ll go through relevant guidance documents and case studies from Pfizer clinical trials.

Speakers
avatar for Jean-Claude Marshall

Jean-Claude Marshall

Head of Clinical Biomarker Technologies in Early Clinical Development, Pfizer
Dr. Marshall is the head of Clinical Biomarker Technologies in Early Clinical Development, Pfizer. His group is responsible for the development and validation of novel biomarkers in early clinical trials, spanning mass spec, flow cytometry, ligand binding and genetic biomarkers.

Chairs
RG

Rose Gonzales

Director, Pfizer


Thursday November 21, 2019 9:35am - 9:55am EST
Essex South (3rd Floor) - Westin Copley 10 Huntington Avenue, Boston, MA 02116 USA

Attendees (1)